Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
6.30
-0.06 (-0.94%)
At close: Apr 2, 2025, 4:00 PM
6.28
-0.02 (-0.32%)
After-hours: Apr 2, 2025, 6:11 PM EDT

Tenax Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
226218752623
Upgrade
Market Cap Growth
3233.86%3233.86%31.60%-81.01%11.69%146.95%
Upgrade
Enterprise Value
134120-411815
Upgrade
Last Close Price
6.366.1921.97178.241664.002976.00
Upgrade
PB Ratio
2.442.380.813.346.185.07
Upgrade
P/TBV Ratio
2.382.380.813.346.185.07
Upgrade
Debt / Equity Ratio
--0.060.540.070.07
Upgrade
Quick Ratio
20.2120.212.731.153.573.17
Upgrade
Current Ratio
20.6020.603.261.743.643.21
Upgrade
Return on Equity (ROE)
-35.17%-35.17%-160.80%-385.12%-732.21%-234.61%
Upgrade
Return on Assets (ROA)
-22.48%-22.48%-68.21%-147.02%-306.43%-93.21%
Upgrade
Return on Capital (ROIC)
-24.22%-24.22%-94.43%-202.10%-416.33%-138.99%
Upgrade
Earnings Yield
-7.68%-8.06%-117.68%-221.89%-123.88%-41.97%
Upgrade
FCF Yield
-6.46%-6.78%-90.10%-228.78%-41.43%-39.52%
Upgrade
Buyback Yield / Dilution
-14109.70%-14109.70%-1250.92%-43.00%--
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q